nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclopirox—Nail disorder—Bleomycin—testicular cancer	0.0464	0.0464	CcSEcCtD
Ciclopirox—Nail disorder—Ifosfamide—testicular cancer	0.0397	0.0397	CcSEcCtD
Ciclopirox—Nail disorder—Etoposide—testicular cancer	0.0313	0.0313	CcSEcCtD
Ciclopirox—Skin exfoliation—Bleomycin—testicular cancer	0.0288	0.0288	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Ifosfamide—testicular cancer	0.0257	0.0257	CcSEcCtD
Ciclopirox—Skin exfoliation—Ifosfamide—testicular cancer	0.0246	0.0246	CcSEcCtD
Ciclopirox—Pain—Carboplatin—testicular cancer	0.0231	0.0231	CcSEcCtD
Ciclopirox—Skin exfoliation—Cisplatin—testicular cancer	0.0212	0.0212	CcSEcCtD
Ciclopirox—Skin exfoliation—Etoposide—testicular cancer	0.0194	0.0194	CcSEcCtD
Ciclopirox—Nail disorder—Methotrexate—testicular cancer	0.0188	0.0188	CcSEcCtD
Ciclopirox—Nail disorder—Epirubicin—testicular cancer	0.0176	0.0176	CcSEcCtD
Ciclopirox—Burning sensation—Methotrexate—testicular cancer	0.0175	0.0175	CcSEcCtD
Ciclopirox—Alopecia—Chlorambucil—testicular cancer	0.0173	0.0173	CcSEcCtD
Ciclopirox—Burning sensation—Epirubicin—testicular cancer	0.0164	0.0164	CcSEcCtD
Ciclopirox—Nail disorder—Doxorubicin—testicular cancer	0.0163	0.0163	CcSEcCtD
Ciclopirox—Alopecia—Vinblastine—testicular cancer	0.0158	0.0158	CcSEcCtD
Ciclopirox—Face oedema—Cisplatin—testicular cancer	0.0156	0.0156	CcSEcCtD
Ciclopirox—Burning sensation—Doxorubicin—testicular cancer	0.0152	0.0152	CcSEcCtD
Ciclopirox—Alopecia—Bleomycin—testicular cancer	0.0134	0.0134	CcSEcCtD
Ciclopirox—Erythema—Bleomycin—testicular cancer	0.0132	0.0132	CcSEcCtD
Ciclopirox—Alopecia—Dactinomycin—testicular cancer	0.0125	0.0125	CcSEcCtD
Ciclopirox—Erythema—Dactinomycin—testicular cancer	0.0123	0.0123	CcSEcCtD
Ciclopirox—Pain—Chlorambucil—testicular cancer	0.0119	0.0119	CcSEcCtD
Ciclopirox—Immune system disorder—Ifosfamide—testicular cancer	0.0117	0.0117	CcSEcCtD
Ciclopirox—Skin exfoliation—Methotrexate—testicular cancer	0.0116	0.0116	CcSEcCtD
Ciclopirox—Alopecia—Ifosfamide—testicular cancer	0.0114	0.0114	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Epirubicin—testicular cancer	0.0114	0.0114	CcSEcCtD
Ciclopirox—Dermatitis contact—Epirubicin—testicular cancer	0.0113	0.0113	CcSEcCtD
Ciclopirox—Erythema—Ifosfamide—testicular cancer	0.0113	0.0113	CcSEcCtD
Ciclopirox—Pain—Vinblastine—testicular cancer	0.0109	0.0109	CcSEcCtD
Ciclopirox—Skin exfoliation—Epirubicin—testicular cancer	0.0109	0.0109	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Doxorubicin—testicular cancer	0.0105	0.0105	CcSEcCtD
Ciclopirox—Dermatitis contact—Doxorubicin—testicular cancer	0.0104	0.0104	CcSEcCtD
Ciclopirox—Skin exfoliation—Doxorubicin—testicular cancer	0.0101	0.0101	CcSEcCtD
Ciclopirox—Immune system disorder—Cisplatin—testicular cancer	0.0101	0.0101	CcSEcCtD
Ciclopirox—Alopecia—Cisplatin—testicular cancer	0.00985	0.00985	CcSEcCtD
Ciclopirox—Pruritus—Chlorambucil—testicular cancer	0.00982	0.00982	CcSEcCtD
Ciclopirox—Erythema—Cisplatin—testicular cancer	0.0097	0.0097	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00951	0.00951	CcSEcCtD
Ciclopirox—Immune system disorder—Etoposide—testicular cancer	0.00922	0.00922	CcSEcCtD
Ciclopirox—Eczema—Epirubicin—testicular cancer	0.00921	0.00921	CcSEcCtD
Ciclopirox—Pain—Bleomycin—testicular cancer	0.00919	0.00919	CcSEcCtD
Ciclopirox—Eye pain—Epirubicin—testicular cancer	0.00916	0.00916	CcSEcCtD
Ciclopirox—Alopecia—Etoposide—testicular cancer	0.00902	0.00902	CcSEcCtD
Ciclopirox—Skin disorder—Ifosfamide—testicular cancer	0.00892	0.00892	CcSEcCtD
Ciclopirox—Pain—Dactinomycin—testicular cancer	0.00857	0.00857	CcSEcCtD
Ciclopirox—Eczema—Doxorubicin—testicular cancer	0.00852	0.00852	CcSEcCtD
Ciclopirox—Eye pain—Doxorubicin—testicular cancer	0.00848	0.00848	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.0082	0.0082	CcSEcCtD
Ciclopirox—Face oedema—Epirubicin—testicular cancer	0.00799	0.00799	CcSEcCtD
Ciclopirox—Headache—Vinblastine—testicular cancer	0.00797	0.00797	CcSEcCtD
Ciclopirox—Pain—Ifosfamide—testicular cancer	0.00785	0.00785	CcSEcCtD
Ciclopirox—Skin disorder—Cisplatin—testicular cancer	0.00769	0.00769	CcSEcCtD
Ciclopirox—Pruritus—Bleomycin—testicular cancer	0.0076	0.0076	CcSEcCtD
Ciclopirox—Dry skin—Epirubicin—testicular cancer	0.00758	0.00758	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00751	0.00751	CcSEcCtD
Ciclopirox—Face oedema—Doxorubicin—testicular cancer	0.00739	0.00739	CcSEcCtD
Ciclopirox—Skin disorder—Etoposide—testicular cancer	0.00705	0.00705	CcSEcCtD
Ciclopirox—Dry skin—Doxorubicin—testicular cancer	0.00702	0.00702	CcSEcCtD
Ciclopirox—Rash—Bleomycin—testicular cancer	0.00678	0.00678	CcSEcCtD
Ciclopirox—Pain—Cisplatin—testicular cancer	0.00677	0.00677	CcSEcCtD
Ciclopirox—Dermatitis—Bleomycin—testicular cancer	0.00677	0.00677	CcSEcCtD
Ciclopirox—Pruritus—Ifosfamide—testicular cancer	0.0065	0.0065	CcSEcCtD
Ciclopirox—Rash—Dactinomycin—testicular cancer	0.00632	0.00632	CcSEcCtD
Ciclopirox—Pain—Etoposide—testicular cancer	0.0062	0.0062	CcSEcCtD
Ciclopirox—Rash—Ifosfamide—testicular cancer	0.00579	0.00579	CcSEcCtD
Ciclopirox—Dermatitis—Ifosfamide—testicular cancer	0.00579	0.00579	CcSEcCtD
Ciclopirox—Immune system disorder—Methotrexate—testicular cancer	0.00552	0.00552	CcSEcCtD
Ciclopirox—Alopecia—Methotrexate—testicular cancer	0.0054	0.0054	CcSEcCtD
Ciclopirox—Erythema—Methotrexate—testicular cancer	0.00532	0.00532	CcSEcCtD
Ciclopirox—Immune system disorder—Epirubicin—testicular cancer	0.00517	0.00517	CcSEcCtD
Ciclopirox—Pruritus—Etoposide—testicular cancer	0.00513	0.00513	CcSEcCtD
Ciclopirox—Alopecia—Epirubicin—testicular cancer	0.00506	0.00506	CcSEcCtD
Ciclopirox—Rash—Cisplatin—testicular cancer	0.00499	0.00499	CcSEcCtD
Ciclopirox—Dermatitis—Cisplatin—testicular cancer	0.00499	0.00499	CcSEcCtD
Ciclopirox—Erythema—Epirubicin—testicular cancer	0.00498	0.00498	CcSEcCtD
Ciclopirox—Immune system disorder—Doxorubicin—testicular cancer	0.00478	0.00478	CcSEcCtD
Ciclopirox—Alopecia—Doxorubicin—testicular cancer	0.00468	0.00468	CcSEcCtD
Ciclopirox—Erythema—Doxorubicin—testicular cancer	0.00461	0.00461	CcSEcCtD
Ciclopirox—Rash—Etoposide—testicular cancer	0.00457	0.00457	CcSEcCtD
Ciclopirox—Dermatitis—Etoposide—testicular cancer	0.00457	0.00457	CcSEcCtD
Ciclopirox—Headache—Etoposide—testicular cancer	0.00454	0.00454	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.0045	0.0045	CcSEcCtD
Ciclopirox—Skin disorder—Methotrexate—testicular cancer	0.00422	0.00422	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00421	0.00421	CcSEcCtD
Ciclopirox—Skin disorder—Epirubicin—testicular cancer	0.00395	0.00395	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.0039	0.0039	CcSEcCtD
Ciclopirox—Pain—Methotrexate—testicular cancer	0.00372	0.00372	CcSEcCtD
Ciclopirox—Skin disorder—Doxorubicin—testicular cancer	0.00365	0.00365	CcSEcCtD
Ciclopirox—Pain—Epirubicin—testicular cancer	0.00348	0.00348	CcSEcCtD
Ciclopirox—Pain—Doxorubicin—testicular cancer	0.00322	0.00322	CcSEcCtD
Ciclopirox—Pruritus—Methotrexate—testicular cancer	0.00307	0.00307	CcSEcCtD
Ciclopirox—Pruritus—Epirubicin—testicular cancer	0.00288	0.00288	CcSEcCtD
Ciclopirox—Rash—Methotrexate—testicular cancer	0.00274	0.00274	CcSEcCtD
Ciclopirox—Dermatitis—Methotrexate—testicular cancer	0.00274	0.00274	CcSEcCtD
Ciclopirox—Headache—Methotrexate—testicular cancer	0.00272	0.00272	CcSEcCtD
Ciclopirox—Pruritus—Doxorubicin—testicular cancer	0.00266	0.00266	CcSEcCtD
Ciclopirox—Rash—Epirubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Ciclopirox—Dermatitis—Epirubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Ciclopirox—Headache—Epirubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Ciclopirox—Rash—Doxorubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Ciclopirox—Dermatitis—Doxorubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Ciclopirox—Headache—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
